Giannino Del Sal Selected Research

Breast Neoplasms (Breast Cancer)

11/2023	Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
10/2023	Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
12/2020	Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment.
1/2020	Expression and subcellular localization of the bromodomain-containing protein 7 is a prognostic biomarker in breast cancer.
4/2018	Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells.
1/2018	Complexes formed by mutant p53 and their roles in breast cancer.
1/2017	Glucocorticoid receptor signalling activates YAP in breast cancer.
1/2017	PIN1 in breast development and cancer: a clinical perspective.
2/2016	YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.
4/2014	Metabolic control of YAP and TAZ by the mevalonate pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giannino Del Sal Research Topics

Disease

55	Neoplasms (Cancer) 02/2024 - 05/2002
12	Breast Neoplasms (Breast Cancer) 11/2023 - 06/2013
5	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2015
4	Carcinogenesis 01/2020 - 10/2015
3	Infections 12/2017 - 03/2010
3	Triple Negative Breast Neoplasms 01/2017 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 12/2017 - 05/2015
2	Inflammation (Inflammations) 01/2017 - 04/2015
2	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2013 - 11/2011
1	Tics (Tic) 02/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Premature Aging 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Fibrosis (Cirrhosis) 01/2019
1	Hepatitis B 12/2017
1	Hyperinsulinism (Hyperinsulinemia) 01/2017
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2016
1	Ischemia 10/2015
1	Diabetic Angiopathies (Diabetic Angiopathy) 04/2015
1	Wilms Tumor (Wilm's Tumor) 12/2013
1	Genomic Instability 05/2013

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2004
7	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2021 - 07/2004
5	Oncogene Proteins (Oncogene Protein)IBA 02/2024 - 01/2015
5	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2013
5	Transcription Factors (Transcription Factor)IBA 08/2014 - 03/2003
3	Serine (L-Serine)FDA Link 11/2023 - 01/2022
3	Phosphotransferases (Kinase)IBA 01/2022 - 11/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2006
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	ChromatinIBA 02/2024 - 01/2021
2	UbiquitinIBA 02/2024 - 01/2022
2	Essential Amino AcidsIBA 11/2023 - 10/2023
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2023 - 10/2023
2	eprenetapoptIBA 04/2018 - 01/2016
2	Genetic Markers (Genetic Marker)IBA 01/2018 - 11/2015
2	NF-kappa B (NF-kB)IBA 01/2018 - 04/2015
2	EnzymesIBA 01/2017 - 03/2010
2	Proteasome InhibitorsIBA 01/2017 - 01/2016
2	Mutant Proteins (Protein, Mutant)IBA 01/2017 - 01/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 06/2010
2	AntigensIBA 01/2017 - 12/2013
2	IntegrasesIBA 01/2014 - 03/2010
1	Protect-ItIBA 02/2024
1	Therapeutic UsesIBA 01/2024
1	Amino Acids FDA Link 10/2023
1	ras GTPase-Activating Proteins (ras-GAP)IBA 06/2023
1	Threonine (L-Threonine)FDA Link 01/2022
1	N(2),N(2),7-trimethylguanosineIBA 01/2022
1	phytobacteriomycin (PBM)IBA 01/2022
1	AndrogensIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	trimethylguanosine synthaseIBA 01/2022
1	telomerase RNA (bTR)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	TESIBA 01/2021
1	HeterochromatinIBA 01/2021
1	DNA Transposable Elements (Element, IS)IBA 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 12/2020
1	human ERBB2 proteinIBA 12/2020
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	MethyltransferasesIBA 01/2019
1	AntioxidantsIBA 04/2018
1	ThioredoxinsIBA 04/2018
1	Heme Oxygenase-1IBA 04/2018
1	Auranofin (Ridaura)FDA Link 04/2018
1	Aflatoxin B1 (Aflatoxin B)IBA 12/2017
1	NIMA-Interacting Peptidylprolyl IsomeraseIBA 01/2017
1	HLA-A*02:01 antigenIBA 01/2017
1	quinone (benzoquinone)IBA 01/2017
1	EpitopesIBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2017
1	Protein SIBA 01/2017
1	Codon (Codons)IBA 04/2016
1	Cyclin BIBA 02/2016
1	Cyclin AIBA 02/2016
1	carfilzomibIBA 01/2016
1	Dasatinib (BMS 354825)FDA Link 11/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2015
1	IsomerasesIBA 10/2015
1	Bortezomib (Velcade)FDA Link 05/2015
1	CytokinesIBA 12/2014
1	ChemokinesIBA 12/2014
1	Mevalonic Acid (Mevalonate)IBA 04/2014
1	CateninsIBA 12/2013
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2013

Therapy/Procedure

12	Therapeutics 01/2019 - 08/2008
2	Immunotherapy 01/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2019 - 11/2014
1	Investigational Therapies (Experimental Therapy) 01/2021